The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


NASONEX



PCO ManufacturingDPR0465/008/001

Main Information

Trade NameNASONEX
Active SubstancesMOMETASONE FUROATE
Dosage FormNasal drops, suspension
Licence HolderPCO Manufacturing
Licence NumberDPR0465/008/001

Group Information

ATC CodeR01AD09 mometasone

Status

License statusAuthorised
Licence Issued03/08/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsNo document available
Package LeafletNo document available
Public Assessment ReportNo document available
« Back